Sanofi SA's Fiscal Year is From January To December.
The item "Price-Earnings-Ratio" stands at 10.35 as of 09/30/2025.
As of the end of Sanofi SA's third quarter, the item "Price Earnings Ratio" stands at 10.35. This represents an increase of 40.03 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -76.07 percent compared to the value the year prior.
The 1 year change in percent is -76.07.
The 3 year change in percent is -21.73.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Price Earnings Ratio | 905,699,262,464.00 |
![]() | Johnson & Johnson - Price Earnings Ratio | 486,508,953,600.00 |
![]() | AbbVie Inc - Price Earnings Ratio | 399,570,305,024.00 |
![]() | Roche Holding AG - Price Earnings Ratio | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Price Earnings Ratio | 280,205,508,085.11 |